Mont-Saint-Guibert, Belgium - Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the Company plans to participate at the following conferences in September 2021:

2021 Wells Fargo Virtual Healthcare Conference

Dates: Thursday, September 9 - Friday, September 10, 2021

Presentation date: Thursday, September 9

Time: 11:20 a.m. ET / 05:20 p.m. CET

Presenter: Filippo Petti, CEO

A webcast link will be available on the Events section of the Celyad Oncologywebsite.

H.C. Wainwright 23rd Annual Global Investment Conference

Dates: Monday, September 13 - Wednesday, September 15, 2021

Presentation: On-demand starting September 13, 7 a.m. ET / 1 p.m. CET

Presenter: Filippo Petti, CEO

Baird's 2021 Virtual Global Healthcare Conference

Dates: Tuesday, September 14 - Wednesday, September 15, 2021

Presentation date: Tuesday, September 14

Time: 3:45 p.m. ET / 9:45 p.m. CET

Presenter: Filippo Petti, CEO

Download press release(s)
Communiqué de presse
Press Release

Attachments

  • Original document
  • Permalink

Disclaimer

Celyad Oncology SA published this content on 01 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 September 2021 05:11:05 UTC.